Document is current
Any future updates will be listed below
-
Authors
Morel, Sarah M. G.
Wu, Shuyang
Kendall, Timothy J.
Guha, Indra N.
Fallowfield, Jonathan A.
- License Information
-
More Information
Article History
Received: 31 August 2025
Accepted: 18 December 2025
First Online: 31 January 2026
Competing interests
: T.J.K. serves as a consultant or advisory board member for Resolution Therapeutics, Clinnovate Health, HistoIndex, Fibrofind, Kynos Therapeutics, Perspectum, Concept Life Sciences, Servier Laboratories, Taiho Oncology, Roche, and Jazz Pharmaceuticals, has received speakers’ fees from Servier Laboratories, Jazz Pharmaceuticals, Astrazeneca, HistoIndex, and Incyte Corporation. J.A.F. serves as a consultant and/or advisory board member for Resolution Therapeutics, Kynos Therapeutics, Gyre Therapeutics, Ipsen, River 2 Renal Corp., Stimuliver, Guidepoint and ICON plc, has received speakers’ fees from HistoIndex, Resolution Therapeutics and Société internationale de développement professionnel continu Cléo and research grant funding from GlaxoSmithKline and Genentech. S.M.G.M., S.W., and I.N.G. declare no financial or non-financial competing interests.
